Randomized controlled smoking cessation study: transient increase in plasma high density lipoprotein but no change in lipoprotein oxidation resistance

REFERENCES

• Hammond EC. Smoking in relation to the death rates of one million men and women. National Cancer Institute Monographs 1966; 19: 127–204.
   PubMedGoogle Scholar
• Doll R, Peto R, Wheatley K, Gray R, Sutherland I. Mortality in relation to smoking: 40 years' observations on male British doctors. Br Med J 1994; 309: 901–10.
   Google Scholar
• Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. HDL as a protective factor against coronary heart disease. The Framingham Study. Am J Med 1977; 62: 707–14.
   Google Scholar
• Miller NE, Fdrde OH, Thelle DS, Mjds OD. The Trosmd Heart Study. High-density lipoprotein and coronary heart disease: a prospective case-control study. Lancet 1977; 1: 965–7.
   Google Scholar
• Garrison RJ, Kannel WB, Feinleib M, Castelli WP, McNamara PM, Padgett SJ. Cigarette smoking and HDL cholesterol. The Framingham Offspring Study. Atherosclerosis 1978; 30: 17–25.
   PubMed Web of Science ®Google Scholar
• Criqui MH, Wallace RB, Heiss G, Mishkel M, Schonfeld G, Jones GTL. Cigarette smoking and plasma high-density lipoprotein cholesterol. Cir-culation 1980; 62 Suppl 4: 70–6.
   Google Scholar
• Mjds OD. Lipid effects of smoking. Am Heart J 1988; 115: 272–5.
   PubMedGoogle Scholar
• Brischetto CS, Connor WE, Connor SL, Matarazzo JD. Plasma lipid and lipoprotein pro-files of cigarette smokers from randomly selected families: enhancement of hyperlipidemia and de-pression of high-density lipoprotein. Am J Cardiol 1983; 52: 675–80.
   PubMed Web of Science ®Google Scholar
• Allen SS, Hatsukami D, Gorsline J and the Transdermal Nicotine Study Group. Cholesterol changes in smoking cessation using the trans-dermal nicotine system. Prey Med 1994; 23: 190–6.
   Google Scholar
• Terres W, Becker P, Rosenberg A. Changes in cardiovascular risk profile during the cessation of smoking. Am J Med 1994; 97: 242–9.
   Google Scholar
• Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its athero-genicity. N Engl J Med 1989; 320: 915–24.
   Google Scholar
• Regnström J, Nilsson J, Tornvall P, Landou C, Hamsten A. Susceptibility to low-density lipo-protein oxidation and coronary atherosclerosis in man. Lancet 1992; 339: 1183–6.
   Google Scholar
• Church DF, Pryor WA. Free-radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect 1985; 64: 111–26.
   PubMed Web of Science ®Google Scholar
• Pryor WA, Prier DG, Church DF. Electron-spin resonance study of mainstream and sidestream cigarette smoke: nature of the free radicals in gas-phase smoke and in cigarette tar. Environ Health Perspect 1983; 47: 345–55.
   Google Scholar
• KaIra J, Chaudhary AK, Prasad K. Increased production of oxygen free radicals in cigarette smokers. Int J Exp Path 1991; 72: 1–7.
   Google Scholar
• Princen HMG, van Poppet G, Vogelezang C, Buytenhek R, Frans JK. Supplementation with vitamin E but not beta-catotene in vivo protects LDL from lipid peroxidation in vitro. Effect of cigarette smoking. Arterioscler Thromb 1992; 12: 554–62.
   PubMed Web of Science ®Google Scholar
• TOnnesen P, NOrregaard J, Simonsen K, Shwe U. A double-blind trial of a 16-hour transdermal nicotine patch in smoking cessation. N Engl J Med 1991; 325: 311–5.
   PubMed Web of Science ®Google Scholar
• Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 1973; 19: 476–82.
   PubMed Web of Science ®Google Scholar
• Friedewald WT, Levy RI, Frederickson DS. Esti-mation of the concentration of low-density lipo-protein cholesterol in plasma, without use of preparative ultracentrifuge. Clin Chem 1972; 18: 499–502.
   Google Scholar
• Nyyssönen K, Porkkala E, Salonen R, Korpela H, Salonen JT. Increase in oxidation resistance of atherogenic serum lipoproteins following antioxi-dant supplementation: a randomized double-blind placebo-controlled clinical trial. Eur J Clin Nutr 1994; 48: 633–42.
   Google Scholar
• Freeman DJ, Packard CJ. Smoking and plasma lipoprotein metabolism. Clin Sci 1995; 89: 333–42.
   PubMedGoogle Scholar
• Craig WY, Palomaki GE, Haddow JE. Cigarette smoking and serum lipid and lipoprotein concen- trations: an analysis of published data. Br Med J 1989; 298: 784–8.
   Google Scholar
• Stubbe I, Eskilsson J, Nilsson-Ehle P. High-density lipoprotein concentrations increase after stopping smoking. Br Med J 1982; 284: 1511–3.
   Google Scholar
• Gerace TA, Hollis J, Ockene JK, Svendsen K. For the MRFIT Research Group. Smoking ces-sation and change in diastolic blood pressure, body weight, and plasma lipids. Prey Med 1991; 20: 602–20.
   Google Scholar
• Rabkin SW. Effect of cigarette smoking cessation on risk factors for coronary atherosclerosis. Atherosclerosis 1984; 53: 173–84.
   PubMed Web of Science ®Google Scholar
• Nilsson P, Lundgren H, Söderström M, Fagerström K-0, Nilsson-Ehle P. Effects of smoking cessa-tion on insulin and cardiovascular risk factors — a controlled study of 4 months' duration. J Intern Med 1996; 240: 189–94.
   Google Scholar
• Esterbauer H, Striegl G, Puhl H, Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad Res Comms 1989; 6: 67–75.
   PubMed Web of Science ®Google Scholar
• Brown AJ. Acute effects of smoking on anti-oxidant status. J Nutr Biochem 1996; 7: 29–39.
   Google Scholar
• Quensel M, Agardh C-D, Nilsson-Ehle P. Nico-tine does not affect plasma lipoprotein concen-trations in healthy men. Scand J Clin Lab Invest 1989; 49: 149–53.
   Web of Science ®Google Scholar
• Celermajer DS, Sorensen KE, Georgakopoulos D, Bull C, Thomas 0, Robinson J, Deanfield JE. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 1993; 88: 2149–55.
   Google Scholar